Inventor
SENANAYAKE CHRIS H
US29 patents
⚠️ This page may combine multiple inventors who share the name “SENANAYAKE CHRIS H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
12 patentsUS6472563B1Oct 29, 2002
Formoterol tartrate process and polymorph
SEPRACOR INC78 citations97
US6720453B2Apr 13, 2004
Formoterol tartrate polymorph
SEPRACOR INC34 citations96
US7342132B2Mar 11, 2008
Formoterol tartrate process and polymorph
SEPRACOR INC13 citations92
US7253156B2Aug 7, 2007
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
SEPRACOR INC17 citations92
US7145036B2Dec 5, 2006
Formoterol tartrate polymorph
SEPRACOR INC20 citations92
US5952502ASep 14, 1999
2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole
SEPRACOR INC24 citations92
US6822099B2Nov 23, 2004
Method of resolving amlodipine racemate
SEPRACOR INC32 citations88
US7732641B2Jun 8, 2010
Formoterol tartrate process and polymorph
SEPRACOR INC4 citations73
US7468362B2Dec 23, 2008
Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists
SEPRACOR INC3 citations62
US7018995B2Mar 28, 2006
Carbonate and carbamate modified forms of glucocorticoids
SEPRACOR INC4 citations62
US6166018ADec 26, 2000
2R, 4S, R, S- and 2S, 4R, R, S-hydroxyitraconazole
SEPRACOR INC2 citations62
US6455530B1Sep 24, 2002
2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole
SEPRACOR INC0 citations51
MERCK & CO INC
6 patentsUS5424432AJun 13, 1995
Process for the preparation of imidazolutidine
MERCK & CO INC17 citations71
US5858737AJan 12, 1999
Conversion of indene to (1S)-amino-(2R)-indanol free of any stereoisomer, by combination of dioxygenase bioconversion and chemical steps
MERCK & CO INC6 citations67
US5849568ADec 15, 1998
Resolution of racemic indene oxide to yield (1S,2R)-indene oxide using Diplodia gossipina
MERCK & CO INC4 citations61
US5489710AFeb 6, 1996
Regiospecific processes to make cis-1-amino-2-alkanol from diol
MERCK & CO INC1 citations51
US5693812ADec 2, 1997
Polymorphic forms of an angiotensin II antagonist
MERCK & CO INC1 citations49
US5241083AAug 31, 1993
Process for converting the 13-α-hydroxy group of avermectin aglycones
MERCK & CO INC0 citations34